Xia S - Search Results

1

mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial-mesenchymal transition.

Chen Y, Li WW, Peng P, Zhao WH, Tian YJ, Huang Y, Xia S, Chen Y. Chen Y, et al. Among authors: xia s. Acta Pharmacol Sin. 2019 Aug;40(8):1085-1094. doi: 10.1038/s41401-019-0215-y. Epub 2019 Feb 22. Acta Pharmacol Sin. 2019. PMID: 30796356 Free PMC article.

2

Pregabalin attenuates docetaxel-induced neuropathy in rats.

Peng P, Xi Q, Xia S, Zhuang L, Gui Q, Chen Y, Huang Y, Zou M, Rao J, Yu S. Peng P, et al. Among authors: xia s. J Huazhong Univ Sci Technolog Med Sci. 2012 Aug;32(4):586-590. doi: 10.1007/s11596-012-1001-y. Epub 2012 Aug 11. J Huazhong Univ Sci Technolog Med Sci. 2012. PMID: 22886975

3

A new rat model of bone cancer pain produced by rat breast cancer cells implantation of the shaft of femur at the third trochanter level.

Gui Q, Xu C, Zhuang L, Xia S, Chen Y, Peng P, Yu S. Gui Q, et al. Among authors: xia s. Cancer Biol Ther. 2013 Feb;14(2):193-9. doi: 10.4161/cbt.23291. Epub 2012 Dec 19. Cancer Biol Ther. 2013. PMID: 23254954 Free PMC article.

4

Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.

Huang Y, Chen Y, Mei Q, Chen Y, Yu S, Xia S. Huang Y, et al. Among authors: xia s. Oncol Rep. 2013 Jun;29(6):2486-92. doi: 10.3892/or.2013.2357. Epub 2013 Mar 22. Oncol Rep. 2013. PMID: 23525575

5

Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.

Zou M, Xia S, Zhuang L, Han N, Chu Q, Chao T, Peng P, Chen Y, Gui Q, Yu S. Zou M, et al. Among authors: xia s. Int J Oncol. 2013 Jun;42(6):2094-102. doi: 10.3892/ijo.2013.1895. Epub 2013 Apr 12. Int J Oncol. 2013. PMID: 23588221

6

A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.

Huang Y, Xi Q, Chen Y, Wang J, Peng P, Xia S, Yu S. Huang Y, et al. Among authors: xia s. Anticancer Drugs. 2013 Oct;24(9):889-98. doi: 10.1097/CAD.0b013e328363c64e. Anticancer Drugs. 2013. PMID: 23838676

7

Development and validation of a prognostic scale for hospitalized patients with terminally ill cancer in China.

Huang Y, Xi Q, Xia S, Wang X, Liu Y, Huang C, Zheng W, Yu S. Huang Y, et al. Among authors: xia s. Support Care Cancer. 2014 Jan;22(1):145-52. doi: 10.1007/s00520-013-1970-9. Epub 2013 Sep 7. Support Care Cancer. 2014. PMID: 24013570

8

Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer.

Xiao X, Wang S, Xia S, Zou M, Li Y, Wei Y, Mei Q, Chen Y. Xiao X, et al. Among authors: xia s. Onco Targets Ther. 2015 Aug 21;8:2209-14. doi: 10.2147/OTT.S89606. eCollection 2015. Onco Targets Ther. 2015. PMID: 26345293 Free PMC article.

9

The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer.

Xiao XG, Xia S, Zou M, Mei Q, Zhou L, Wang SJ, Chen Y. Xiao XG, et al. Among authors: xia s. Onco Targets Ther. 2015 Dec 3;8:3575-83. doi: 10.2147/OTT.S95149. eCollection 2015. Onco Targets Ther. 2015. PMID: 26664141 Free PMC article.

10

Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation.

Zou M, Li Y, Xia S, Chu Q, Xiao X, Qiu H, Chen Y, Zheng Z, Liu F, Zhuang L, Yu S. Zou M, et al. Among authors: xia s. Cell Physiol Biochem. 2017;44(2):778-791. doi: 10.1159/000485291. Epub 2017 Nov 23. Cell Physiol Biochem. 2017. PMID: 29169152 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,386 results

Search Page

Filters